I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Empagliflozin is associated with lower cardiovascular risk ..:
Dorte Vistisen
;
Bendix Carstensen
;
Patorno Elisabetta
...
https://doi.org/10.1186/s12933-023-01963-9. , 2023
Link:
https://doi.org/10.1186/s12933-023-01963-9
RT Journal T1
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:a2bb1c7f2f2448239e817140320a7e7e&Exemplar=1&LAN=DE A1 Dorte Vistisen A1 Bendix Carstensen A1 Patorno Elisabetta A1 Stefanie Lanzinger A1 Elise Chia-Hui Tan A1 Daisuke Yabe A1 Dae Jung Kim A1 Wayne H.-H. Sheu A1 Cheli Melzer-Cohen A1 Reinhard W. Holl A1 Júlio Núñez A1 Kyoung Hwa Ha A1 Sigrun Halvorsen A1 Gisle Langslet A1 Avraham Karasik A1 Thomas Nyström A1 Leo Niskanen A1 Sonia Guleria A1 Riho Klement A1 Marc Carrasco A1 Johannes Foersch A1 Christina Shay A1 Lisette Koeneman A1 Fabian Hoti A1 Soulmaz Fazeli Farsani A1 Kamlesh Khunti A1 Francesco Zaccardi A1 Anuradhaa Subramanian A1 Krishnarajah Nirantharakumar A1 EMPRISE EU A1 East Asia Study Group PB BMC YR 2023 K1 Empagliflozin K1 Dipeptidyl peptidase-4 inhibitors K1 Type 2 diabetes K1 Cardiovascular disease K1 Heart failure K1 Comparative effectiveness K1 Diseases of the circulatory (Cardiovascular) system K1 RC666-701 JF https://doi.org/10.1186/s12933-023-01963-9 LK http://dx.doi.org/https://doi.org/10.1186/s12933-023-01963-9 DO https://doi.org/10.1186/s12933-023-01963-9 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)